CLR 131 Combined With Radiation for Head and Neck Cancer
NCT04105543
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
CLR 131
Sponsor
University of Wisconsin, Madison
Collaborators
[object Object]
[object Object]